ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB378

Association of Kidney Function with Sepsis-Related Mortality

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Mohty, Ralph, Stanford Medicine, Stanford, California, United States
  • Chertow, Glenn M., Stanford Medicine, Stanford, California, United States
  • Rogers, Angela J, Stanford Medicine, Stanford, California, United States
  • Fielding-Singh, Vikram, Stanford Medicine, Stanford, California, United States
Background

Although chronic kidney disease (CKD) has been associated with mortality in sepsis, literature describing outcomes of sepsis among patients with CKD have reported inconsistent results. We conducted a population-based study to better characterize the outcomes of hospital admissions for sepsis among patients with and without CKD in the United States. We hypothesized that the presence and severity of CKD would be associated with higher risks of mortality and prolonged hospital stay.

Methods

We identified hospitalizations for patients 18 years or older with sepsis or septic shock using the National Inpatient Sample (NIS), an all-payor database containing discharge level data from a 20% stratified sample of discharges from non-VA and non-rehabilitation hospitals in the United States. Sepsis and septic shock, CKD-3, CKD-4/5, and ESKD were identified using International Classification of Diseases, 9th and 10th Revision diagnosis codes. We used logistic regression to determine the odds of mortality and prolonged hospital stay by the presence and severity of CKD, adjusted for patient demographics, comorbidity and severity of illness, geographic region, and hospital characteristics.

Results

We found 20,870,713 admissions in adult patients with sepsis or septic shock from 2010 to 2019. Of these 15,476,852 (74.2%) had normal or near normal kidney function, 3,378,657 (16.2%) had CKD3, 547,172 (2.6%) had CKD4/5, and 1,468,032 (7.0%) had ESKD. Sepsis- and septic shock-associated in-hospital mortality rates for patients with normal or near normal kidney function, CKD-3, CKD-4/5, and ESKD were 11.6%, 13.7%, 16.3%, and 17.9%, respectively. Figure 1 shows adjusted odds of mortality and prolonged hospital stay for CKD stages relative to patients with normal or near normal kidney function.

Conclusion

In this population-based study of admissions involving sepsis and septic shock in the United States, presence and severity of CKD were associated with higher adjusted odds of in-hospital mortality and prolonged hospital stay.

Digital Object Identifier (DOI)